204 science-"University-of-Southern-Denmark--------" positions at City of Hope in United States
Sort by
Refine Your Search
-
). We are one of the few interventional oncology groups in the United States with a basic science lab, large animal tumor model, and several active clinical trials, which enables us to translate new
-
immune checkpoints and ligands on various hematopoietic malignant and solider tumor cells with high-throughput screening and protein engineering approaches developed in the lab, and develop novel cancer
-
involved in cutting-edge technology, research and clinical immunotherapy investigations. We are currently looking for a postdoctoral fellow who will work on improving the therapeutic potential of oncolytic
-
biomedical sciences. · Proficiency in biochemical techniques, molecular biology skills, and cell culture. · Research experience with in vivo animal models. · Evidence of scientific
-
various clinicians and researchers to coordinate biospecimens and informatics. · Develop systematic databases with members on campus. · PhD or MD degree in life or biomedical sciences, or a
-
/riggs-institute/diabetes-complications-and-metabolism/wendong-huang-lab · A Ph.D. or M.D. degree in broad biomedical sciences. · Proficiency in biochemical techniques, molecular biology
-
in biology, chemistry, biochemistry, physiology, nursing, or other related fields. Two or more years of experience in Clinical Research City of Hope is an equal opportunity employer. To learn more
-
and profound knowledge in the field of oncology, cancer biology, immunology, or immunotherapy. · Prior molecular, cancer biology and/or translational research experience and evidence of project
-
with highest potential for improvements in patient care. In short, our science-led business-supported approach means there’s no better place to move your research forward. If you’re looking for a job
-
seeking a Research Associate II to join the T Cell Therapeutics Research Laboratory. This role involves fast-paced research in cutting-edge technology, immunotherapeutic programs, and a commitment to